e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Different aspects of COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of pneumococcal vaccine in patients with chronic respiratory disease
Y. Watanuki, N. Miyazawa, M. Kudo, S. Inoue, H. Goto, T. Kaneko, H. Takahashi, Y. Ishigatsubo (Yokohama, Japan)
Source:
Annual Congress 2007 - Different aspects of COPD exacerbations
Session:
Different aspects of COPD exacerbations
Session type:
Electronic Poster Discussion
Number:
1368
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Watanuki, N. Miyazawa, M. Kudo, S. Inoue, H. Goto, T. Kaneko, H. Takahashi, Y. Ishigatsubo (Yokohama, Japan). Effects of pneumococcal vaccine in patients with chronic respiratory disease. Eur Respir J 2007; 30: Suppl. 51, 1368
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 442s
Year: 2006
No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
Results of vaccination against pneumococcal infection in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Effectiveness of 23-valent pneumococcal polysaccharide vaccine in preventing lower respiratory tract infections complicating chronic respiratory failure
Source: Eur Respir J 2006; 28: Suppl. 50, 576s
Year: 2006
Results of vaccination against pneumococcal infection in patients with chronic heart failure
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
Pneumococcal vaccination in chronic respiratory patients – a cohort study
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006
Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough.
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021
Influenza and pneumococcal vaccination in patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept